GRAND FORKS, N.D.--(BUSINESS WIRE)--NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the appointment of infectious disease expert and vaccine industry leader, R. Gordon Douglas, Jr., M.D., as Chairman of the Company’s Board of Directors.
